🇺🇸 FDA

Drug profile · INN

azithromycin

AZITHROMYCIN

approved
US status
approved
Patents linked
2
News articles
1

Quick answer

azithromycin (AZITHROMYCIN) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.

Key facts

INN azithromycin
Brand AZITHROMYCIN
Route OPHTHALMIC
Formulation TABLET
Originator Amneal Pharma Europe Ltd

Related patents

Search patents →

  1. US 6764997

    Stabilized azithromycin compositions

    Expires Mon Jul 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6365574

    Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof

    Expires Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is azithromycin?

azithromycin (AZITHROMYCIN) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.

What is the brand name for azithromycin?

AZITHROMYCIN is a marketed brand name for azithromycin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of azithromycin?

azithromycin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.